Clinical Trial Update: Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induction chemotherapy and toripalimab followed by radiotherapy for unresectable laryngeal or hypopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Laryngeal Cancer, Hypopharyngeal Cancer | Phase 2 | Status: UNKNOWN